Biotech Daily

Daily news on ASX-listed biotechnology companies

Editorials

Biotech Daily reports daily news on the sector and rarely makes a comment. The following issues have been judged as of concern to the entire sector and we have added our voice. Editor David Langsam takes responsibility for the opinion, except for articles cosigned by analyst Marc Sinatra.

Federal Election 2022 - Biotech Daily Editorial

2021 - The Year In Review

Another Year In The Grass - With Shrooms & E

Editorial: Selective Briefings & ASX Listing Rule 15.7

Budget 2021 Special Edition; Comment & Response

2020 - The Year In Review

A Year In The Grass - Medical Marijuana Review

Budget 2020 Special Edition; Comment & Analysis

Biotech Daily 1st Medical Marijuana Survey

CSIRO, Doherty Distance From 'Tier 1' Sars-Cov-2 Claims

Editorial: Covid-19 Spruikers, Please Stop !

Editorial: Covid-19 Coronavirus Claims

Editorial: The 2019-nCoV Coronavirus (Covid-19)

2019 - The Year In Review

All The Dope On Medicine, Marijuana, Cannabis & Hemp

BNYM & Substantial Shareholder Notices

Federal Election 2019: Policies & Comment

Budget 2019 Comment & Analysis

Your R&D Tax Incentive Is Not Revenue

2018 - The Year In Review

Victoria Election 2018 - Biotech Daily Editorial

Budget 2018 & Comment

Editorial: Something Is Rotten In Optiscan

Editorial: Doing The Deal

2017 - The Year In Review - CEO, Chairman, Kamikaze of the Year 

Senator Michaelia Cash Appointed Innovation Minister - Biotech Daily Editorial Comment - Dec 20, 2017

Biotech Daily 12th Birthday Editorial

Biotech Daily Editorial: Selective Briefings - Oct 11, 2017

Budget 2017: 1st MRFF Funding, Steady As She Goes - Biotech Daily Editorial Comment

Welcome To 2017

2016 - The Year In Review: Money, Malcolm & Medical Marijuana

Ausbiotech, Biotech Daily: 'Don't Cut The 45% R&D Tax Incentive' - Sep 13, 2016

Federal Election 2016: Promises, Evidence And Credibility - Jun 30, 2016

Biotech Daily Policy On Mega-Day-Traders

Budget 2016: Not Much For Biotech - Details, Comment: Research Australia, Biotech Daily
University of Melbourne - Mar 3, 4, 2016

NHMRC $3.3m For Windfarm Health Impacts AMA Position, Biotech Daily Comment - Mar 22, 2016

2015 - The Year In review

PM Malcolm Turnbull Launches $1.1b Innovation, Science Agenda Comment: Bio-Melbourne Network, Biotech Daily, Ausbiotech, Medicines Australia - Dec 7, 8, 2015

Mesoblast, The Nasdaq & Comparative Valuations - Nov 19, 2015

Biotech Daily 10th Birthday Editorial - Nov 6, 2015

PM Turnbull Puts Innovation, Chris Pyne Centre of Agenda - Comment

Benitec - Another Band Fails To Make It Big In The USA - Aug 19, 2015

2014 - The Year In Review

Victoria State Election And State Biotechnology Policies

Biotech Daily 9th Birthday Editorial

Federal Government 'Action Plan' Comment: Cochlear, Medicines Australia, Biotech Daily, Ausbiotech

BRIL Group Senate Innovation Submission: Set Aside 25% Of $20bn MRFF For Commercialization

Biota Sacks More Staff, Closes Australian Operations - Biotech Daily Comment: A Disgrace

Federal Budget 2014 - $20b Research Fund, Details, Comment

Trials, Tribulations and Transparency - Apr 2, 2014

2013 The Year In Review

Biotech Daily Is 8

Federal Election 2013 Editorial: No One Offering A $1bn Phase III Trials Fund

2012 - The Year In Review

Mervyn, Mervyn, Mervyn !

Biotech Daily's 7th Birthday Editorial

Three Strikes For Two Strikes Board Spill Policy - Oct 16, 2012

Patrys, Citigroup And Hiding Behind Nominee Companies - Feb 15, 2012

2011 The Year in review

Chemgenex, Phylogica Trading & Transparency - May 20, 2011

Federal Budget - May 11, 2011

Disclosure & Transparency - Apr 1, 2011

The Year In Review - Dec 16, 2010

Biotech Daily 5th Birthday Editorial

Federal Election 2010 Editorial: Nepotism Our Best Hope - Aug 19, 2010

Political Changes Ring Uncertainty For Biotech - Jun 24, 2010

The Year In Review - Dec 17, 2009

4th Birthday Editorial - Nov 6, 2009

Commercialisation Australia - 'Radical Media Release, Fabulous Logo' - Oct 21, 2009

ASIC Acquires ASX Powers - Now For Transparency - Aug 24, 2009

Ausbiotech, Aspermont & Independent Journalism - Aug 5, 2009

BRIL Group Proposal For Commonwealth Commercialization Institute - July 6, 2009

ASX In Wonderland III: Corporate Regulation - June 25, 2009

Biotechs, The Law & Matters Of Principle - June 18, 2009

Fermiscan v Prof James: Who Breaks A Butterfly On A Wheel? - April 28, 2009

Why Is There Good News? - Apr 14, 2009

Once In An Economic Lifetime Opportunity - Jan 30, 2009

2008 - The Year In Review

Genetic Technologies: Friends Of Mervyn & The Perils Of Owner-Drivers

Submission to the National Innovation Review - May 21, 2008

Budget 2008 Editorial - May 14, 2008

Opes Prime:Caveat Bloody Emptor - April 4, 2008

Conlicts of Interest and Transparency - January 19, 2007

Federal Budget 2009 Surprises Sector: Far More Than Expected

Subscribe to Biotech Daily

TOP